Notice on the 2nd Extraordinary General Meeting in 2026
Filed with SSE · · 7 pages · Chinese
China National Medicines Corporation Ltd. on 6ix
Earlier from China National Medicines
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Announcement on Convening Performance Briefing for 2025 and Q1 2026
- Announcement on Renewing Engagement of Accounting Firm for 2026
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Amending Some Clauses of the Articles of Association
Later from China National Medicines
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
- Announcement on Opening of a Special Account for Temporarily Supplementing Working Capital with Raised Funds and Signing of a Regulatory Agreement
- Announcement on Resolutions of the 41st Meeting of the 8th Board of Directors
- Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2026
Follow China National Medicines into a list and get an email when it puts out news.
Follow China National Medicines